This article has been corrected from a previous version to correct misinformation regarding the current name of Syzygy Biotech.
Syzygy Biotech, a Grand Rapids, Mich.-based PCR reagents shop, has received a $100,000 investment from the Michigan Pre-Seed Capital Fund, fund administrator Ann Arbor Spark said today.
Syzygy, which was formed under the name Seedus Biotech, manufactures low-cost reagents such as Taq polymerases and master mixes for use in DNA amplification.
According to its website, the company is also currently developing a high-fidelity polymerase that it claims combines Taq's ease of use with equal or greater replication accuracy.
Syzygy is one of several companies to have recently received investments totaling about $1.8 million from the Michigan Pre-Seed Capital Fund, an equity fund administered by Ann Arbor Spark that invests in technology-based companies to support business formation and acceleration.
Last month, Syzygy also won a $100,000 SmartZone award at the Great Lakes Entrepreneur's Quest business plan contest held at Michigan State University. That award was also funded through the Michigan Pre-Seed Capital Fund.